Iwicki Mark T. - 11 Aug 2025 Form 4 Insider Report for Third Harmonic Bio, Inc. (THRD)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
14 Aug 2025, 16:06:58 UTC
Prior SEC filing
26 Jun 2025
Next SEC filing
27 Oct 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Natalie Holles, Attorney-in-Fact

Key filing fact

Iwicki Mark T. filed Form 4 for Third Harmonic Bio, Inc. (THRD) on 14 Aug 2025.

Key facts

  • This page summarizes Iwicki Mark T.'s Form 4 filing for Third Harmonic Bio, Inc. (THRD).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 14 Aug 2025, 16:06.

Change

  • Previous filing in this sequence was filed on 26 Jun 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001415537 Primary reporting owner

Iwicki Mark T

Relationship
Director
Address
C/O THIRD HARMONIC BIO, INC., 1700 MONTGOMERY STREET, SUITE 210, SAN FRANCISCO
Signature
/s/ Natalie Holles, Attorney-in-Fact
Signature date
14 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

THRD transaction

Common Stock

Other

Transaction value
Shares
-128,631
Change %
-100%
Price
Shares after
0
Date
11 Aug 2025
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

THRD transaction Derivative

Stock Option

Other

Transaction value
$0
Shares
-83,296
Change %
-100%
Price
$0.000000
Shares after
0
Date
11 Aug 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
83,296
Exercise price
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Transaction reported is a cancellation of shares of common stock in connection with the dissolution of the Issuer.

Footnote F2

The reporting person received a liquidation distribution of $5.35 per share of Common Stock from Issuer.

Footnote F3

Represents payment of the liquidation distribution of $5.35 per share less the exercise price of such options.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .